Should Arkema's Sustainability Milestones Influence Strategy Considerations for Investors in ENXTPA:AKE?
Reviewed by Sasha Jovanovic
- In October 2025, Arkema achieved ISCC PLUS certification for its Boretto, Italy plant's waterborne acrylic resins and completed a €40 million modernization and decarbonization project at its Lacq/Mourenx site in France.
- These advancements highlight Arkema's commitment to reducing its environmental impact through both certified sustainable raw materials and significant cuts in greenhouse gas and sulfur emissions.
- We'll explore how Arkema's milestone in low-carbon waterborne resin certification fits into its broader investment narrative around specialty materials.
Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
Arkema Investment Narrative Recap
To be comfortable holding Arkema stock, an investor has to believe in the long-term value of specialty materials and Arkema’s ability to weather cyclical demand across construction, automotive, and advanced coatings. The recent ISCC PLUS certification in Italy and green modernization in France reinforce Arkema’s positioning in sustainable solutions, but do not shift the near-term catalyst of volume recovery in weak end-markets, or change the biggest risk, which remains muted demand visibility especially in Europe and North America.
One relevant announcement is Arkema's €500 million green bond issuance in September 2025, supporting sustainable investment. This, together with the Boretto certification, highlights ongoing capital allocation toward eco-friendly innovation; however, robust demand recovery in key end-markets remains the most significant near-term driver of earnings improvement.
In contrast, persistent macro uncertainty and weak demand in core markets remain a risk investors should keep in mind, especially if...
Read the full narrative on Arkema (it's free!)
Arkema's outlook anticipates €10.3 billion in revenue and €464.5 million in earnings by 2028. This is based on analysts' expectations of 2.9% annual revenue growth and a €273.5 million earnings increase from the current level of €191.0 million.
Uncover how Arkema's forecasts yield a €70.62 fair value, a 41% upside to its current price.
Exploring Other Perspectives
Nine individual fair value estimates from the Simply Wall St Community range from €44.06 to €158.35 per share. While opinions vary widely, the key catalyst remains Arkema’s investments in low-carbon and specialty solutions, which could influence earnings as global sustainability standards evolve.
Explore 9 other fair value estimates on Arkema - why the stock might be worth 12% less than the current price!
Build Your Own Arkema Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Arkema research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Arkema research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arkema's overall financial health at a glance.
Seeking Other Investments?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 38 best rare earth metal stocks of the very few that mine this essential strategic resource.
- These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
- Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:AKE
Arkema
Manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally.
Good value with adequate balance sheet and pays a dividend.
Similar Companies
Market Insights
Community Narratives

